Technology News and Research

RSS

Study: Seniors in long-term care facilities are at high risk of head injuries

A study by Simon Fraser University researchers has found seniors in long-term care facilities are at high risk of head injuries - nearly 40 per cent of those who fall experience head impact.

8 Oct 2013

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Chemists at The Scripps Research Institute (TSRI) have devised a new technique for connecting drug molecules to antibodies to make advanced therapies.

8 Oct 2013

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

7 Oct 2013

GSK Adds Another Program To Isis Antisense Collab

...

7 Oct 2013

First Edition: October 7, 2013

Today's headlines include reports detailing the ins and outs of the federal government's online health insurance markeplace as well as the latest from Capitol Hill on the shutdown.

7 Oct 2013

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

7 Oct 2013

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that a Services Agreement has been signed with the German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen (GRCBDS) whereby GRCBDS will provide pharmaceutical development and GMP manufacturing services for Kiadis Pharma's ongoing Phase II clinical study with ATIR™.

7 Oct 2013

General surgeon receives Distinguished Service Award from ACS

Last night the Board of Regents of the American College of Surgeons (ACS) presented Barbara Lee Bass, MD, FACS, Houston, TX, with the ACS Distinguished Service Award at the Convocation ceremony preceding the official opening of the 2013 Clinical Congress of the American College of Surgeons.

7 Oct 2013

Brain & Behavior Research Foundation to honor 7 scientists for exceptional research on mental health

The Brain & Behavior Research Foundation celebrates the transformative power of neuroscience and psychiatric research to improve the lives of those with mental illness. Seven exceptional scientists will be honored at the Annual National Awards Dinner at the Pierre Hotel in New York City on Friday, October 25, 2013.

7 Oct 2013

Newly discovered compound could be developed as antifungal drug to treat fungal infections

On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult and expensive.

7 Oct 2013

Boreal Genomics announces completion of $18 million Series C financing round

Boreal Genomics, a privately held provider of technology for non-invasive genomic profiling of tumors from blood plasma of cancer patients, announced today the completion of an $18 million Series C financing round.

5 Oct 2013

OrthoSensor receives CE Mark approval to launch VERASENSE Knee System

OrthoSensor announced today plans to launch its VERASENSE Knee System in European markets after recently receiving CE Mark approval. VERASENSE is the first integrated intelligent orthopaedic device to provide surgeons with real-time quantitative data on knee implant positioning, limb alignment and soft tissue balance during total knee replacement surgery.

5 Oct 2013

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.

5 Oct 2013

'Personalised medicine': Topic of free public lecture at the University of Greenwich

'Personalised medicine' is the topic of a free public lecture at the University of Greenwich. Personalised medicine, or precision medicine, as it is sometimes known, is a key goal for 21st century healthcare. Currently, many medicines are either ineffective or unsafe in certain patient populations, whereas the aim for personalised medicine is to target the right treatment to the right patient group.

5 Oct 2013

Researchers receive prestigious European Health Award for project on new psychoactive drugs

The prestigious European Health Award 2013 has been awarded to Dr Ornella Corazza for the Recreational Drugs European Network (ReDNet), a collaborative prevention project on new psychoactive drugs led by University of Hertfordshire researchers Professor Fabrizio Schifano and Dr Corazza.

5 Oct 2013

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Researchers from the FEMSA Center of Biotechnology at Technologic of Monterrey (ITESM) designed a technology that uses grated carrot to obtain phenolic compounds that have a potential to prevent cancer, and cardiovascular and neurodegenerative diseases.

5 Oct 2013

Technology News and Research

Study: Seniors in long-term care facilities are at high risk of head injuries

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

GSK Adds Another Program To Isis Antisense Collab

First Edition: October 7, 2013

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

General surgeon receives Distinguished Service Award from ACS

Brain & Behavior Research Foundation to honor 7 scientists for exceptional research on mental health

Newly discovered compound could be developed as antifungal drug to treat fungal infections

Boreal Genomics announces completion of $18 million Series C financing round

OrthoSensor receives CE Mark approval to launch VERASENSE Knee System

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

'Personalised medicine': Topic of free public lecture at the University of Greenwich

Researchers receive prestigious European Health Award for project on new psychoactive drugs

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Using Botox as weight loss tool in rats

ABC50plus launches new and user-friendly website

Merck Canada Awards $15.5M To Four Universities

Designer Baby Patent Awarded To 23Andme

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News